Sign in
4

Changes in Ownership

Evolent Health, Inc. Filed Acc 0001232583-17-000002

CEO, Valence Health sold 6,000 shares at $20.11 ($120,660)

  • CEO, Valence Health acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WIGGINTON STEVE · CEO, Valence Health

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-01 Exercise or conversion : show line 1 in the form +6,000 $3.84 $23,040 365,692 D
2017-03-01 Sale : show line 2 in the form −6,000 $20.11 $120,660 359,692 D
Open-market sales · 6,000 sh · avg $20.11 · $120,660

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-01 Exercise or conversion : show line 3 in the form Class A Common Stock Option (right to buy) −6,000 $3.84 2024-04-01 6,000 429,680 D
Loading xslF345X03/primary_doc.xml…